Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Rapid Micro Biosystems, Inc. RPID
$0.90
+$0.02 (2.16%)
На 18:04, 12 мая 2023
+788.89%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
35860222.00000000
-
week52high
5.40
-
week52low
0.83
-
Revenue
17133000
-
P/E TTM
-1
-
Beta
0.00000000
-
EPS
-1.37000000
-
Last Dividend
0.00000000
-
Next Earnings Date
05 мая 2023 г. в 12:30
Описание компании
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| JP Morgan | Neutral | Overweight | 16 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 11 мая 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 07 мар 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 15 февр 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 15 ноя 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| KENNEDY LEWIS MANAGEMENT LP | A | 2904490 | 29398 | 03 июн 2022 г. |
| KENNEDY LEWIS MANAGEMENT LP | A | 2035441 | 20602 | 03 июн 2022 г. |
| KENNEDY LEWIS MANAGEMENT LP | A | 2875092 | 5938 | 02 июн 2022 г. |
| KENNEDY LEWIS MANAGEMENT LP | A | 2014839 | 4162 | 02 июн 2022 г. |
| KENNEDY LEWIS MANAGEMENT LP | A | 2869154 | 27703 | 01 июн 2022 г. |
| KENNEDY LEWIS MANAGEMENT LP | A | 2010677 | 19414 | 01 июн 2022 г. |
| KENNEDY LEWIS MANAGEMENT LP | A | 2841451 | 11759 | 31 мая 2022 г. |
| KENNEDY LEWIS MANAGEMENT LP | A | 1991263 | 8241 | 31 мая 2022 г. |
| KENNEDY LEWIS MANAGEMENT LP | A | 2829692 | 882 | 27 мая 2022 г. |
| KENNEDY LEWIS MANAGEMENT LP | A | 1983022 | 618 | 27 мая 2022 г. |
Новостная лента
Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference
GlobeNewsWire
05 янв 2023 г. в 08:00
LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 41st Annual J.P. Morgan Healthcare Conference.
Rapid Micro Biosystems, Inc. (RPID) Q3 2022 Earnings Call Transcript
Seeking Alpha
13 ноя 2022 г. в 13:03
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Mike Beaulieu - Investor Relations Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Dan Arias - Stifel Rachel Vatnsdal - JPMorgan Stephanie Yan - Cowen Operator Hello. My name is Lisa and I will be your conference operator today.
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
10 ноя 2022 г. в 09:47
Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of -2.70% and 20.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Hill International, Rapid Micro Biosystems See Activist Investor Action
Market Watch
02 сент 2022 г. в 21:10
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.
Rapid Micro Biosystems, Inc. (RPID) CEO Rob Spignesi on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
13 авг 2022 г. в 11:03
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET Company Participants Mike Beaulieu - CFA Vice President, Investor Relations & Corporate Communications Rob Spignesi - Chief Executive Officer Sean Wirtjes - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Dan Arias - Stifel Stephanie Yan - Cowen Rachel Cascio - JPMorgan Operator Ladies and gentlemen, thank you for standing by and welcome to the Rapid Micro Biosystems Second Quarter 2022 Earnings Conference Call. I would now like to turn the call over to Mike Beaulieu, Investor Relations.